It has been reported that the key enzyme of FAO is abnormally expressed in malignant tumors, especially in ovarian cancer, and the abnormally high expression of CPT1A is closely related to the poor prognosis of ovarian cancer patients [10, 11]. Here, CPT1A is linked to ovarian carcinoma.